GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » Shares Buyback Ratio %

Argenica Therapeutics (ASX:AGN) Shares Buyback Ratio % : -14.07 (As of Jun. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Argenica Therapeutics Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Argenica Therapeutics's current shares buyback ratio was -14.07%.

Argenica Therapeutics Shares Buyback Ratio % Historical Data

The historical data trend for Argenica Therapeutics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argenica Therapeutics Shares Buyback Ratio % Chart

Argenica Therapeutics Annual Data
Trend Jun21 Jun22 Jun23
Shares Buyback Ratio %
- -18.79 -13.15

Argenica Therapeutics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shares Buyback Ratio % Get a 7-Day Free Trial - -18.79 - -13.15 -0.81

Argenica Therapeutics Shares Buyback Ratio % Calculation

Argenica Therapeutics's Shares Buyback Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2022 ) - Shares Outstanding (EOP) (A: Jun. 2023 )) / Shares Outstanding (EOP) (A: Jun. 2022 )
=(86.9222 - 98.3508) / 86.9222
=-13.15%

Argenica Therapeutics's Shares Buyback Ratio for the quarter that ended in Dec. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2023 ) - Shares Outstanding (EOP) (A: Dec. 2023 )) / Shares Outstanding (EOP) (A: Jun. 2023 )
=(98.3508 - 99.1508) / 98.3508
=-0.81%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Argenica Therapeutics Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Argenica Therapeutics's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Argenica Therapeutics (ASX:AGN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » Shares Buyback Ratio %
Comparable Companies
ASX:NOX ASX:RAD ASX:EZZ ASX:PAA ASX:BIO ASX:ACW ASX:CYP ASX:1AI ASX:BTC ASX:IXC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
117 Broadway, Unit 4, Nedlands, WA, AUS, 6009
Website
https://www.argenica.com.au
Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.

Argenica Therapeutics (ASX:AGN) Headlines

No Headlines